Kyoung Jin Kim
Overview
Explore the profile of Kyoung Jin Kim including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
62
Citations
320
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kim J, Shin C, Jung I, Park S, Lee D, Yu J, et al.
J Cachexia Sarcopenia Muscle
. 2025 Mar;
16(2):e13760.
PMID: 40035123
Background: Muscle quality, represented by myosteatosis, is recognized as an important factor in sarcopenia. In this study, we aimed to determine the associations between myosteatosis, muscle strength and physical performance...
2.
Lee S, Hong N, Kim G, Li J, Lin X, Seager S, et al.
Yonsei Med J
. 2025 Feb;
66(3):187-194.
PMID: 39999994
Purpose: Rare diseases occur in <50 per 100000 people and require lifelong management. However, essential epidemiological data on such diseases are lacking, and a consecutive monitoring system across time and...
3.
Ha J, Jung K, Kim K, Ahn S, Kim H, Chung Y
Endocrinol Metab (Seoul)
. 2025 Feb;
PMID: 39933434
Background: Denosumab is a potent anti-resorptive agent widely used for osteoporosis. However, its discontinuation results in a 'rebound phenomenon' of rapid bone loss, necessitating transition to alternative anti-resorptive therapies. Despite...
4.
Kim J, Kim K, Choi J, Kim K, Song E, Yu J, et al.
Endocrinol Metab (Seoul)
. 2025 Jan;
40(1):125-134.
PMID: 39805575
Backgruound: Antithyroid drug (ATD) treatment is the preferred initial treatment for Graves' disease (GD) in South Korea, despite higher treatment failure rates than radioactive iodine (RAI) therapy or thyroidectomy. This...
5.
Kim K, Ahn S, Park S, Choi J, Bae G, Kim H, et al.
Eur J Endocrinol
. 2024 Sep;
191(3):361-369.
PMID: 39287498
Importance: Osteoporosis-related fractures are associated with increased mortality risk among postmenopausal women, yet the impact of antiosteoporotic medications on mortality is not fully understood. Objective: This study evaluates the effect...
6.
Kim K, Choi J, Shin S, Kim J, Kim K, Kim S
Endocrinol Metab (Seoul)
. 2024 Aug;
39(4):659-663.
PMID: 39099390
Treatment patterns and preferences for patients with Graves' disease (GD) vary across countries. In this study, we assessed the initial therapies and subsequent treatment modalities employed for GD in real-world...
7.
Park S, Kong S, Kim K, Ahn S, Hong N, Ha J, et al.
Endocrinol Metab (Seoul)
. 2024 Jul;
39(4):539-551.
PMID: 39015028
This comprehensive review critically examines the detrimental impacts of endocrine-disrupting chemicals (EDCs) on bone health, with a specific focus on substances such as bisphenol A (BPA), per- and polyfluoroalkyl substances...
8.
Kim K, Baek S, Yu M, Shin S, Cho S, Rhee Y, et al.
JBMR Plus
. 2024 Jun;
8(7):ziae065.
PMID: 38868595
Data on epidemiology and secular trend in primary hyperparathyroidism (PHPT) in adults are relatively limited in Asian countries. This study aims to provide an overview of the secular trends in...
9.
Lee S, Yu M, Hong N, Kim K, Kim H, Rhee Y, et al.
Diabetes Res Clin Pract
. 2024 May;
213:111712.
PMID: 38768867
Introduction: We investigated the relationship between sodium-glucose cotransporter-2 inhibitor (SGLT2i) and fracture in elderly women diagnosed with type 2 diabetes mellitus (T2DM) and newly prescribed antidiabetic medications (ADMs). Material And...
10.
Kim K, Ha J, Kim S, Kim J, Lee S, Choi H, et al.
Endocrinol Metab (Seoul)
. 2024 May;
39(2):267-282.
PMID: 38693817
This review article investigates solid organ transplantation-induced osteoporosis, a critical yet often overlooked issue, emphasizing its significance in post-transplant care. The initial sections provide a comprehensive understanding of the prevalence...